23627/34351US=64 / Câncer
Harvey RD, Silberman J, Lonmial S. The PI3 kinase/akt pathway as a therapeutic target in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 309-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

PI3 QUINASE; AKT; TERAPEUTICO NO MIELOMA MULTIPLO; MIELOMA MULTIPLO. TERAPIAS


23628/34351US=64 / Câncer
Frost P, Lichtenstein A. The mammalian target of rapamycin and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 323-30. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

RAPAMICINA EM MAMIFEROS; MIELOMA MULTIPLO; CELULAS EUCARIOTICAS; IMUNO-HISTOQUIMICA


23629/34351US=64 / Câncer
Dai Y, Grant S. CDK inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 331-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

INIBIDORES DE CDK NO MIELOMA MULTIPLO; PROGRESSAO DO CICLO CELULAR; QUINASES DEPENDENTES DE CICLINA


23630/34351US=64 / Câncer
Jiménez-Zepeda VH, Stewart AK. Fibroblast growth, factor receptor 3 and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 365-78. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

CRESCIMENTO DE FIBROBLASTOS; RECEPTOR DO FACTOR DE 3; MIELOMA MULTIPLO; TRANSLOCACOES CROMOSSOMICAS


23631/34351US=64 / Câncer
Hideshima T. Histone deacetylase inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 379-92. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MIELOMA MULTIPLO


23632/34351US=64 / Câncer
Mollinedo F. Death receptors in multiple myeloma and therapeutic opportunities. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 393-419. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

RECEPTORES DE MORTE EM MIELOMA MULTIPLO; MIELOMA MULTIPLO


23633/34351US=64 / Câncer
Chauhan D, Singh A, Anderson K. Proteasome inhibitors as therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 421-32. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

TERAPIA EM MIELOMA MULTIPLO. INIBIDORES DE PROTEASSOMA; HOMEOSTASE CELULAR NORMAL; AGENTES ANTICANCERIGENOS. INIBIDORES DE PROTEASSOMA


23634/34351US=64 / Câncer
Mark TM, Pearse RN. Pathophysiology of bone disease in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 435-54. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

DOENCA OSSEA DO MIELOMA MULTIPLO. FISIOPATOLOGIA; MIELOMA MULTIPLO; MALIGNIDADE DE CELULAS PLASMATICAS; CRESCIMENTO DA MEDULA OSSEA


23635/34351US=64 / Câncer
Sloan MJ, Raje N. Anemia and erythropoietic growth factors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 455-68. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

ANEMIA; ERITROPOIESE EM MIELOMA MULTIPLO. FATORES DE CRESCIMENTO


23636/34351US=64 / Câncer
Narayanan S, Tong FC. Percutaneous vertebroplasty and balloon kyphoplasty for the treatment of acute painful pathologic fracture. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 469-89. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

VERTEBROPLASTIA PERCUTANEA; CIFOPLASTIA; TRATAMENTO DE FRATURA DOLOROSA


23637/34351US=64 / Câncer
Durie BGM. The role of anatomic and functional imaging in myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 491-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

PAPEL DA IMAGEM ANATOMICA EM MIELOMA; PAPEL DA IMAGEM FUNCIONAL EM MIELOMA


23638/34351US=64 / Câncer
Ailawadhi S, Chanan-Khan A. Management of multiple myeloma patients with renal dysfunction. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 499-516. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MIELOMA MULTIPLO COM DISFUNCAO RENAL. TRATAMENTO


23639/34351US=64 / Câncer
Simpson L, Gertz M. Waldenstrom's macroglobulinemia. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 519-50. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

MACROGLOBULINEMIA DE WALDENSTROM; WM


23640/34351US=64 / Câncer
Sanchorawala V. AL (immunoglobulin light-chain amyloidosis). In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 551-69. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

AL; AMILOIDOSE IMUNOGLOBULINA


23641/34351US=64 / Câncer
Dispenzieri A. POEMS syndrome and other atypical plasma cell disorders. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 571-623. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

SINDROME POEMS; DOENCAS DE CELULAS ATIPICAS DE PLASMA


23642/34351US=64 / Câncer
Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 625-49. (Comtemporary Hematology) ISBN 978-1-934115-82-4.

GAMOPATIA MONOCLONAL


23643/34351US=65 / Biol/Mol
Puente XS, Ordóñez GR, López-Otín C. Protease genomics and the cancer degradome. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 3-15. ISBN 978-0-387-69056-8.

GENOMICA DE PROTEASE; CANCER DEGRADOME; DEGRADOME HUMANO; PESQUISA; REPERTORIO INIBIDOR DA PROTEASE; DEGRADOMES MAMIFEROS


23644/34351US=65 / Biol/Mol
Kappelhoff R, Wilson CH, Overall CM. The CLIP-CHIP: a focused oligonucleotide microarray platform for transcriptome analysis of the complete human and murine cancer degradomes. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 17-35. ISBN 978-0-387-69056-8.

CLIP CHIP; MICROARRAY; OLIGONUCLEOTIDEO; ANALISE DO TRANSCRIPTOMA; DEGRADOMES CANCEROSAS HUMANAS; MURINAS; PROTEASES; PROTEASE WEB; MICROARRAYS TRANSCRIPTOMICAS; TECNOLOGIA MICROARRAYS


23645/34351US=65 / Biol/Mol
Schwartz DR, Moin K, Weber E, Sloane BF. The Hu/Mu ProtIn Chip: a custom dual-species oligonucleotide microarray for profiling degradome gene expression in tumors and their microenvironment. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 37-47. ISBN 978-0-387-69056-8.

HU/MU CHIP PROTIN; MICROARRAY; OLIGONUCLEOTIDEO PERSONALIZADO; EXPRESSAO DO GENE; DEGRADOME


23646/34351US=65 / Biol/Mol
Pennington CJ, Nuttall RK, Sampieri-Ramirez C, Wallard M, Pilgrim S, Edwards DR. Quantitative real-time PCR analysis of degradome gene expression. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 49-65. ISBN 978-0-387-69056-8.

QUANTITATIVO EM TEMPO REAL; ANALISE DE PCR; EXPRESSAO DO GENE DEGRADOME


Primeira | Anterior | Próxima | Última